+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Spinal Devices & Biologics Market - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030- Product Image
Spinal Devices & Biologics Market - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030- Product Image
Sale

Spinal Devices & Biologics Market - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030

  • PDF Icon

    Report

  • 188 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6012075
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Spinal Devices & Biologics Market grew from USD 11.38 billion in 2024 to USD 13.30 billion in 2025. It is expected to continue growing at a CAGR of 16.74%, reaching USD 28.82 billion by 2030.

In today’s dynamic healthcare environment, spine care sits at the nexus of technological innovation, demographic shifts, and evolving clinical protocols. This executive summary provides a concise yet comprehensive overview of the spinal devices and biologics sector, highlighting the market’s foundational pillars, recent advancements, and emerging opportunities. By examining the interplay between product innovations-ranging from next-generation implants to advanced biologic therapies-and the broader healthcare ecosystem, readers will gain a clear understanding of the critical drivers reshaping the industry.

Through precise analysis of market segmentation, regulatory influences, and regional dynamics, this introduction sets the stage for a deeper exploration of transformative trends. It also outlines the impact of policy decisions, including newly implemented tariffs, on supply chains and cost structures. Ultimately, this section establishes the core context and scope for stakeholders-including device manufacturers, healthcare providers, investors, and policymakers-to navigate the complexities of spine care innovation with confidence.

Transformative Shifts in the Spinal Devices and Biologics Landscape

The spinal devices and biologics landscape has undergone transformative shifts driven by converging forces. Technological breakthroughs in navigation, robotics and augmented reality have elevated surgical precision, while advanced imaging techniques have enabled real-time visualization of complex anatomies. Concurrently, the integration of biologic therapies-particularly next-generation growth factors and synthetics-has accelerated fusion rates and enhanced patient outcomes. In parallel, the rise of value-based care models and outcome-driven reimbursement has compelled manufacturers to demonstrate clinical efficacy and cost efficiency.

Moreover, demographic trends such as an aging global population and increasing prevalence of degenerative disc disease have amplified demand for both minimally invasive procedures and biologic augmentation. Private equity and strategic investors have further propelled consolidation and M&A activity, reshaping competitive dynamics. As providers seek to optimize OR utilization, there is a marked shift toward outpatient settings and ambulatory surgery centers. These combined forces are not only redefining product development roadmaps but also driving a paradigm shift in how spinal interventions are conceived, delivered and reimbursed.

Cumulative Impact of United States Tariffs in 2025 on Spine Devices and Biologics

In 2025, the cumulative effect of new tariffs on imported materials and final goods has introduced both challenges and strategic inflection points. Tariffs levied on components sourced from key regions have elevated costs by 5-15%, directly impacting raw materials such as titanium alloys, PEEK polymers and hydroxyapatite. Supply chain disruptions have led to extended lead times for critical spinal implants and graft materials, compelling firms to diversify their supplier base and accelerate near-shoring initiatives.

At the biologics level, increased import duties on recombinant proteins and proprietary growth factors have squeezed margins for small and mid-sized innovators, forcing many to renegotiate contracts and explore domestic manufacturing partnerships. Larger corporations have leveraged economies of scale to absorb a greater share of cost increases, but downstream effects include price adjustments and tighter negotiations with payers. In response, forward-leaning organizations are investing in regional production hubs, optimizing inventory management and engaging in risk-sharing agreements to maintain competitive positioning in a tariff-constrained environment.

Key Insights Across Critical Market Segmentation

Market segmentation provides the foundation for targeted growth strategies. On the basis of product type, the industry is dissected into spinal biologics and spinal implants, with the former encompassing bone grafts and growth factors, and the latter comprising interbody devices, spinal cord stimulators, and spinal plates and screws. Within bone grafts, allografts, autografts and synthetics present distinct value propositions, while interbody solutions branch into cage designs and disk replacement technologies. Analyzing procedure type reveals a trajectory toward minimally invasive approaches-including endoscopic and percutaneous techniques-alongside ongoing demand for open surgery. Diagnosis applications span complex deformity, degenerative disk disease and trauma cases, with kyphosis and scoliosis representing specialized subsets of complex deformities. End-user segmentation covers ambulatory surgery centers, hospitals (both private and public) and specialty clinics, each with unique procurement and utilization patterns. Finally, age group dynamics ranging from pediatric to adult and geriatric-with young elderly, old elderly and very old elderly cohorts-underscore evolving treatment protocols driven by patient physiology and comorbidity profiles.

These layers of segmentation yield critical insights. Synthetic bone grafts and next-generation growth factors are capturing share from traditional autografts, driven by consistency and reduced donor-site morbidity. Expandable interbody cages are rapidly gaining adoption, supported by clinical data demonstrating improved alignment restoration. The transition to percutaneous, image-guided procedures is outpacing open approaches, enabled by innovation in instrumentation. Complex deformity cases continue to be concentrated within tertiary care hospitals, whereas ASC and specialty clinics are emerging as high-growth venues for routine degenerative interventions. The geriatric population-particularly the very old elderly-exhibits rising demand for biologic-enhanced fusion solutions, while the pediatric segment sustains stable volumes through corrective procedures.

Regional Trends Shaping the Spinal Devices and Biologics Market

Regional dynamics are shaping competitive advantage and investment decisions. In the Americas, the United States remains the epicenter of spine innovation, fueled by premium reimbursement frameworks and a robust private sector. However, tariff pressures and shifting healthcare policies are prompting stakeholders to explore near-shore manufacturing and logistics partnerships. Latin America presents a mixed landscape: Brazil and Mexico lead in procedure volumes, yet affordability and reimbursement constraints temper market growth.

Across Europe, Middle East & Africa, Germany, France and the United Kingdom command significant share due to established clinical infrastructure and favorable reimbursement. Price transparency initiatives and centralized tendering in certain EMEA markets drive cost containment, while private hospitals in the Gulf Cooperation Council region are investing heavily in advanced surgical suites.

In Asia-Pacific, rapid urbanization and increasing healthcare expenditure underpin the fastest regional CAGR. China and India are bolstering domestic production of both implants and biologics, aided by favorable government policies. Japan’s mature market continues to prioritize high-end technologies, and Southeast Asian nations are gradually expanding reimbursement for advanced spinal procedures. These regional patterns underscore the need for tailored go-to-market approaches and local supplier partnerships.

Leading Companies Steering Market Advancements

A constellation of industry leaders and agile innovators is steering market advancements. Medtronic PLC maintains its leadership through a diversified portfolio of implants, navigation platforms and biologic solutions, while Stryker Corporation intensifies its focus on robotic-assisted spine surgery and modular implant systems. NuVasive, Inc. drives the minimally invasive interbody segment with proprietary lateral access techniques. Orthofix Medical Inc. and Innovasis, Inc. specialize in advanced bone graft materials and biologic augmentation, differentiating through novel delivery mechanisms.

Smith & Nephew PLC and Exactech, Inc. continue to refine expandable interbody cages and disk replacement devices, backed by rigorous clinical studies. DJO, LLC and Invictus Medical LLC lead in neuromodulation and laser-assisted interbody fusion, respectively. Integra LifeSciences Holdings Corporation and Össur Group diversify with composite biologics and external support technologies, bridging surgical and conservative care. Wright Medical Group N.V. expands its footprint in extremity and trauma-based spinal solutions. In parallel, Aesculap Implant Systems, LLC and Kohlberg & Company, LLC drive operational excellence and strategic M&A, strengthening their presence across core implant and biologic categories. This competitive ecosystem fosters rapid innovation cycles and encourages partnerships across disciplines.

Actionable Recommendations for Industry Leaders

Industry leaders must adopt a multifaceted strategy to capitalize on emerging opportunities. First, investing in regional manufacturing hubs mitigates tariff exposure and enhances supply chain resilience. Second, accelerating the development of synthetic biologics and next-generation growth factors can address the shifting preference away from autografts. Third, optimizing minimally invasive instrumentation and platforms for endoscopic and percutaneous workflows will meet growing demand for outpatient procedures.

Fourth, establishing strategic alliances with payers to develop value-based contracting models can secure favorable reimbursement and bundle pricing. Fifth, pursuing selective M&A or joint ventures with technology disruptors in navigation, robotics and AI will strengthen competitive positioning. Finally, tailoring product portfolios and market entry strategies to the specific demographics, clinical preferences and regulatory frameworks of each region will ensure sustained growth and market penetration.

Executive Conclusion on Future Trajectory

The spinal devices and biologics sector stands at a pivotal juncture, defined by rapid technological progress, shifting policy landscapes and evolving patient demographics. Navigating the complexities of tariffs, reimbursement reform and competitive consolidation requires proactive adaptation. Organizations that align R&D investment with clinical needs-particularly in synthetic biologics and minimally invasive solutions-will emerge as frontrunners.

Moreover, building resilient supply chains through regional manufacturing, enhancing regulatory agility and forging collaborative partnerships across the healthcare continuum will be critical. By leveraging data-driven insights and embracing value-based care models, market participants can demonstrate superior outcomes and cost efficiency.

Market Segmentation & Coverage

This research report categorizes the Spinal Devices & Biologics Market to forecast the revenues and analyze trends in each of the following sub-segmentations:

  • Spinal Biologics
    • Bone Grafts
      • Allografts
      • Autografts
      • Synthetics
    • Growth Factors
  • Spinal Implants
    • Interbody Devices
      • Cages
      • Disk Replacement Devices
    • Spinal Cord Stimulators
    • Spinal Plates and Screws
  • Minimally Invasive Surgery
    • Endoscopic Procedures
    • Percutaneous Procedures
  • Open Surgery
  • Complex Deformity
    • Kyphosis
    • Scoliosis
  • Degenerative Disk Disease
  • Trauma Cases
  • Ambulatory Surgery Centers
  • Hospitals
    • Private Hospitals
    • Public Hospitals
  • Specialty Clinics
  • Adult
  • Geriatric
    • Old Elderly
    • Very Old Elderly
    • Young Elderly
  • Pediatric

This research report categorizes the Spinal Devices & Biologics Market to forecast the revenues and analyze trends in each of the following sub-regions:

  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

This research report categorizes the Spinal Devices & Biologics Market to delves into recent significant developments and analyze trends in each of the following companies:

  • Acuity Surgical Devices, LLC
  • Aesculap Implant Systems, LLC
  • DJO, LLC
  • Exactech, Inc.
  • Innovasis, Inc.
  • Integra LifeSciences Holdings Corporation
  • Invictus Medical LLC
  • Kohlberg & Company, LLC
  • Medtronic PLC
  • NuVasive, Inc.
  • Orthofix Medical Inc.
  • Smith & Nephew PLC
  • Stryker Corporation
  • Wright Medical Group N.V.
  • Össur Group

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Spinal Devices & Biologics Market, by Product Type
8.1. Introduction
8.2. Spinal Biologics
8.2.1. Bone Grafts
8.2.1.1. Allografts
8.2.1.2. Autografts
8.2.1.3. Synthetics
8.2.2. Growth Factors
8.3. Spinal Implants
8.3.1. Interbody Devices
8.3.1.1. Cages
8.3.1.2. Disk Replacement Devices
8.3.2. Spinal Cord Stimulators
8.3.3. Spinal Plates and Screws
9. Spinal Devices & Biologics Market, by Procedure Type
9.1. Introduction
9.2. Minimally Invasive Surgery
9.2.1. Endoscopic Procedures
9.2.2. Percutaneous Procedures
9.3. Open Surgery
10. Spinal Devices & Biologics Market, by Diagnosis Application
10.1. Introduction
10.2. Complex Deformity
10.2.1. Kyphosis
10.2.2. Scoliosis
10.3. Degenerative Disk Disease
10.4. Trauma Cases
11. Spinal Devices & Biologics Market, by End User
11.1. Introduction
11.2. Ambulatory Surgery Centers
11.3. Hospitals
11.3.1. Private Hospitals
11.3.2. Public Hospitals
11.4. Specialty Clinics
12. Spinal Devices & Biologics Market, by Age Group
12.1. Introduction
12.2. Adult
12.3. Geriatric
12.3.1. Old Elderly
12.3.2. Very Old Elderly
12.3.3. Young Elderly
12.4. Pediatric
13. Americas Spinal Devices & Biologics Market
13.1. Introduction
13.2. Argentina
13.3. Brazil
13.4. Canada
13.5. Mexico
13.6. United States
14. Asia-Pacific Spinal Devices & Biologics Market
14.1. Introduction
14.2. Australia
14.3. China
14.4. India
14.5. Indonesia
14.6. Japan
14.7. Malaysia
14.8. Philippines
14.9. Singapore
14.10. South Korea
14.11. Taiwan
14.12. Thailand
14.13. Vietnam
15. Europe, Middle East & Africa Spinal Devices & Biologics Market
15.1. Introduction
15.2. Denmark
15.3. Egypt
15.4. Finland
15.5. France
15.6. Germany
15.7. Israel
15.8. Italy
15.9. Netherlands
15.10. Nigeria
15.11. Norway
15.12. Poland
15.13. Qatar
15.14. Russia
15.15. Saudi Arabia
15.16. South Africa
15.17. Spain
15.18. Sweden
15.19. Switzerland
15.20. Turkey
15.21. United Arab Emirates
15.22. United Kingdom
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Acuity Surgical Devices, LLC
16.3.2. Aesculap Implant Systems, LLC
16.3.3. DJO, LLC
16.3.4. Exactech, Inc.
16.3.5. Innovasis, Inc.
16.3.6. Integra LifeSciences Holdings Corporation
16.3.7. Invictus Medical LLC
16.3.8. Kohlberg & Company, LLC
16.3.9. Medtronic PLC
16.3.10. NuVasive, Inc.
16.3.11. Orthofix Medical Inc.
16.3.12. Smith & Nephew PLC
16.3.13. Stryker Corporation
16.3.14. Wright Medical Group N.V.
16.3.15. Össur Group
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. SPINAL DEVICES & BIOLOGICS MARKET MULTI-CURRENCY
FIGURE 2. SPINAL DEVICES & BIOLOGICS MARKET MULTI-LANGUAGE
FIGURE 3. SPINAL DEVICES & BIOLOGICS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY PROCEDURE TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY PROCEDURE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY DIAGNOSIS APPLICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY DIAGNOSIS APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY AGE GROUP, 2024 VS 2030 (%)
FIGURE 16. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. SPINAL DEVICES & BIOLOGICS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. SPINAL DEVICES & BIOLOGICS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. SPINAL DEVICES & BIOLOGICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY SPINAL BIOLOGICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY BONE GRAFTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY ALLOGRAFTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY AUTOGRAFTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY SYNTHETICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY BONE GRAFTS, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY GROWTH FACTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY SPINAL BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY SPINAL IMPLANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY INTERBODY DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY CAGES, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY DISK REPLACEMENT DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY INTERBODY DEVICES, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY SPINAL CORD STIMULATORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY SPINAL PLATES AND SCREWS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY SPINAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY ENDOSCOPIC PROCEDURES, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY PERCUTANEOUS PROCEDURES, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY OPEN SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY DIAGNOSIS APPLICATION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY COMPLEX DEFORMITY, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY KYPHOSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY SCOLIOSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY COMPLEX DEFORMITY, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY DEGENERATIVE DISK DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TRAUMA CASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY ADULT, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY OLD ELDERLY, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY VERY OLD ELDERLY, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY YOUNG ELDERLY, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY SPINAL BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY BONE GRAFTS, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY SPINAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY INTERBODY DEVICES, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY DIAGNOSIS APPLICATION, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY COMPLEX DEFORMITY, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 63. AMERICAS SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 65. ARGENTINA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 66. ARGENTINA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY SPINAL BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 67. ARGENTINA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY BONE GRAFTS, 2018-2030 (USD MILLION)
TABLE 68. ARGENTINA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY SPINAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 69. ARGENTINA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY INTERBODY DEVICES, 2018-2030 (USD MILLION)
TABLE 70. ARGENTINA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 71. ARGENTINA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
TABLE 72. ARGENTINA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY DIAGNOSIS APPLICATION, 2018-2030 (USD MILLION)
TABLE 73. ARGENTINA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY COMPLEX DEFORMITY, 2018-2030 (USD MILLION)
TABLE 74. ARGENTINA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 75. ARGENTINA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 76. ARGENTINA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 77. ARGENTINA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 78. BRAZIL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 79. BRAZIL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY SPINAL BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 80. BRAZIL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY BONE GRAFTS, 2018-2030 (USD MILLION)
TABLE 81. BRAZIL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY SPINAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 82. BRAZIL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY INTERBODY DEVICES, 2018-2030 (USD MILLION)
TABLE 83. BRAZIL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 84. BRAZIL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
TABLE 85. BRAZIL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY DIAGNOSIS APPLICATION, 2018-2030 (USD MILLION)
TABLE 86. BRAZIL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY COMPLEX DEFORMITY, 2018-2030 (USD MILLION)
TABLE 87. BRAZIL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 88. BRAZIL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 89. BRAZIL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 90. BRAZIL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 91. CANADA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 92. CANADA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY SPINAL BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 93. CANADA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY BONE GRAFTS, 2018-2030 (USD MILLION)
TABLE 94. CANADA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY SPINAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 95. CANADA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY INTERBODY DEVICES, 2018-2030 (USD MILLION)
TABLE 96. CANADA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 97. CANADA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
TABLE 98. CANADA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY DIAGNOSIS APPLICATION, 2018-2030 (USD MILLION)
TABLE 99. CANADA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY COMPLEX DEFORMITY, 2018-2030 (USD MILLION)
TABLE 100. CANADA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 101. CANADA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 102. CANADA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 103. CANADA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 104. MEXICO SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 105. MEXICO SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY SPINAL BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 106. MEXICO SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY BONE GRAFTS, 2018-2030 (USD MILLION)
TABLE 107. MEXICO SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY SPINAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 108. MEXICO SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY INTERBODY DEVICES, 2018-2030 (USD MILLION)
TABLE 109. MEXICO SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 110. MEXICO SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
TABLE 111. MEXICO SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY DIAGNOSIS APPLICATION, 2018-2030 (USD MILLION)
TABLE 112. MEXICO SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY COMPLEX DEFORMITY, 2018-2030 (USD MILLION)
TABLE 113. MEXICO SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 114. MEXICO SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 115. MEXICO SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 116. MEXICO SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 117. UNITED STATES SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 118. UNITED STATES SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY SPINAL BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 119. UNITED STATES SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY BONE GRAFTS, 2018-2030 (USD MILLION)
TABLE 120. UNITED STATES SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY SPINAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 121. UNITED STATES SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY INTERBODY DEVICES, 2018-2030 (USD MILLION)
TABLE 122. UNITED STATES SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 123. UNITED STATES SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
TABLE 124. UNITED STATES SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY DIAGNOSIS APPLICATION, 2018-2030 (USD MILLION)
TABLE 125. UNITED STATES SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY COMPLEX DEFORMITY, 2018-2030 (USD MILLION)
TABLE 126. UNITED STATES SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 127. UNITED STATES SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 128. UNITED STATES SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 129. UNITED STATES SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 130. UNITED STATES SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 131. ASIA-PACIFIC SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 132. ASIA-PACIFIC SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY SPINAL BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 133. ASIA-PACIFIC SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY BONE GRAFTS, 2018-2030 (USD MILLION)
TABLE 134. ASIA-PACIFIC SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY SPINAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 135. ASIA-PACIFIC SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY INTERBODY DEVICES, 2018-2030 (USD MILLION)
TABLE 136. ASIA-PACIFIC SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 137. ASIA-PACIFIC SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
TABLE 138. ASIA-PACIFIC SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY DIAGNOSIS APPLICATION, 2018-2030 (USD MILLION)
TABLE 139. ASIA-PACIFIC SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY COMPLEX DEFORMITY, 2018-2030 (USD MILLION)
TABLE 140. ASIA-PACIFIC SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 141. ASIA-PACIFIC SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 142. ASIA-PACIFIC SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 143. ASIA-PACIFIC SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 144. ASIA-PACIFIC SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 145. AUSTRALIA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 146. AUSTRALIA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY SPINAL BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 147. AUSTRALIA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY BONE GRAFTS, 2018-2030 (USD MILLION)
TABLE 148. AUSTRALIA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY SPINAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 149. AUSTRALIA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY INTERBODY DEVICES, 2018-2030 (USD MILLION)
TABLE 150. AUSTRALIA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 151. AUSTRALIA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
TABLE 152. AUSTRALIA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY DIAGNOSIS APPLICATION, 2018-2030 (USD MILLION)
TABLE 153. AUSTRALIA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY COMPLEX DEFORMITY, 2018-2030 (USD MILLION)
TABLE 154. AUSTRALIA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 155. AUSTRALIA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 156. AUSTRALIA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 157. AUSTRALIA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 158. CHINA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 159. CHINA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY SPINAL BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 160. CHINA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY BONE GRAFTS, 2018-2030 (USD MILLION)
TABLE 161. CHINA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY SPINAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 162. CHINA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY INTERBODY DEVICES, 2018-2030 (USD MILLION)
TABLE 163. CHINA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 164. CHINA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
TABLE 165. CHINA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY DIAGNOSIS APPLICATION, 2018-2030 (USD MILLION)
TABLE 166. CHINA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY COMPLEX DEFORMITY, 2018-2030 (USD MILLION)
TABLE 167. CHINA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 168. CHINA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 169. CHINA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 170. CHINA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 171. INDIA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 172. INDIA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY SPINAL BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 173. INDIA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY BONE GRAFTS, 2018-2030 (USD MILLION)
TABLE 174. INDIA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY SPINAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 175. INDIA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY INTERBODY DEVICES, 2018-2030 (USD MILLION)
TABLE 176. INDIA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 177. INDIA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
TABLE 178. INDIA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY DIAGNOSIS APPLICATION, 2018-2030 (USD MILLION)
TABLE 179. INDIA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY COMPLEX DEFORMITY, 2018-2030 (USD MILLION)
TABLE 180. INDIA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 181. INDIA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 182. INDIA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 183. INDIA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 184. INDONESIA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 185. INDONESIA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY SPINAL BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 186. INDONESIA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY BONE GRAFTS, 2018-2030 (USD MILLION)
TABLE 187. INDONESIA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY SPINAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 188. INDONESIA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY INTERBODY DEVICES, 2018-2030 (USD MILLION)
TABLE 189. INDONESIA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 190. INDONESIA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
TABLE 191. INDONESIA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY DIAGNOSIS APPLICATION, 2018-2030 (USD MILLION)
TABLE 192. INDONESIA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY COMPLEX DEFORMITY, 2018-2030 (USD MILLION)
TABLE 193. INDONESIA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 194. INDONESIA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 195. INDONESIA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 196. INDONESIA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 197. JAPAN SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 198. JAPAN SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY SPINAL BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 199. JAPAN SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY BONE GRAFTS, 2018-2030 (USD MILLION)
TABLE 200. JAPAN SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY SPINAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 201. JAPAN SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY INTERBODY DEVICES, 2018-2030 (USD MILLION)
TABLE 202. JAPAN SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 203. JAPAN SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
TABLE 204. JAPAN SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY DIAGNOSIS APPLICATION, 2018-2030 (USD MILLION)
TABLE 205. JAPAN SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY COMPLEX DEFORMITY, 2018-2030 (USD MILLION)
TABLE 206. JAPAN SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 207. JAPAN SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 208. JAPAN SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 209. JAPAN SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 210. MALAYSIA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 211. MALAYSIA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY SPINAL BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 212. MALAYSIA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY BONE GRAFTS, 2018-2030 (USD MILLION)
TABLE 213. MALAYSIA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY SPINAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 214. MALAYSIA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY INTERBODY DEVICES, 2018-2030 (USD MILLION)
TABLE 215. MALAYSIA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 216. MALAYSIA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
TABLE 217. MALAYSIA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY DIAGNOSIS APPLICATION, 2018-2030 (USD MILLION)
TABLE 218. MALAYSIA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY COMPLEX DEFORMITY, 2018-2030 (USD MILLION)
TABLE 219. MALAYSIA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 220. MALAYSIA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 221. MALAYSIA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 222. MALAYSIA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 223. PHILIPPINES SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 224. PHILIPPINES SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY SPINAL BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 225. PHILIPPINES SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY BONE GRAFTS, 2018-2030 (USD MILLION)
TABLE 226. PHILIPPINES SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY SPINAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 227. PHILIPPINES SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY INTERBODY DEVICES, 2018-2030 (USD MILLION)
TABLE 228. PHILIPPINES SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 229. PHILIPPINES SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
TABLE 230. PHILIPPINES SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY DIAGNOSIS APPLICATION, 2018-2030 (USD MILLION)
TABLE 231. PHILIPPINES SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY COMPLEX DEFORMITY, 2018-2030 (USD MILLION)
TABLE 232. PHILIPPINES SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 233. PHILIPPINES SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 234. PHILIPPINES SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 235. PHILIPPINES SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 236. SINGAPORE SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 237. SINGAPORE SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY SPINAL BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 238. SINGAPORE SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY BONE GRAFTS, 2018-2030 (USD MILLION)
TABLE 239. SINGAPORE SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY SPINAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 240. SINGAPORE SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY INTERBODY DEVICES, 2018-2030 (USD MILLION)
TABLE 241. SINGAPORE SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 242. SINGAPORE SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
TABLE 243. SINGAPORE SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY DIAGNOSIS APPLICATION, 2018-2030 (USD MILLION)
TABLE 244. SINGAPORE SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY COMPLEX DEFORMITY, 2018-2030 (USD MILLION)
TABLE 245. SINGAPORE SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 246. SINGAPORE SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 247. SINGAPORE SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 248. SINGAPORE SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 249. SOUTH KOREA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 250. SOUTH KOREA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY SPINAL BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 251. SOUTH KOREA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY BONE GRAFTS, 2018-2030 (USD MILLION)
TABLE 252. SOUTH KOREA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY SPINAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 253. SOUTH KOREA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY INTERBODY DEVICES, 2018-2030 (USD MILLION)
TABLE 254. SOUTH KOREA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 255. SOUTH KOREA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
TABLE 256. SOUTH KOREA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY DIAGNOSIS APPLICATION, 2018-2030 (USD MILLION)
TABLE 257. SOUTH KOREA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY COMPLEX DEFORMITY, 2018-2030 (USD MILLION)
TABLE 258. SOUTH KOREA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 259. SOUTH KOREA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 260. SOUTH KOREA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 261. SOUTH KOREA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 262. TAIWAN SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 263. TAIWAN SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY SPINAL BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 264. TAIWAN SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY BONE GRAFTS, 2018-2030 (USD MILLION)
TABLE 265. TAIWAN SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY SPINAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 266. TAIWAN SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY INTERBODY DEVICES, 2018-2030 (USD MILLION)
TABLE 267. TAIWAN SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 268. TAIWAN SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
TABLE 269. TAIWAN SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY DIAGNOSIS APPLICATION, 2018-2030 (USD MILLION)
TABLE 270. TAIWAN SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY COMPLEX DEFORMITY, 2018-2030 (USD MILLION)
TABLE 271. TAIWAN SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 272. TAIWAN SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 273. TAIWAN SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 274. TAIWAN SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 275. THAILAND SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 276. THAILAND SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY SPINAL BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 277. THAILAND SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY BONE GRAFTS, 2018-2030 (USD MILLION)
TABLE 278. THAILAND SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY SPINAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 279. THAILAND SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY INTERBODY DEVICES, 2018-2030 (USD MILLION)
TABLE 280. THAILAND SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 281. THAILAND SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
TABLE 282. THAILAND SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY DIAGNOSIS APPLICATION, 2018-2030 (USD MILLION)
TABLE 283. THAILAND SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY COMPLEX DEFORMITY, 2018-2030 (USD MILLION)
TABLE 284. THAILAND SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 285. THAILAND SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 286. THAILAND SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 287. THAILAND SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 288. VIETNAM SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 289. VIETNAM SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY SPINAL BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 290. VIETNAM SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY BONE GRAFTS, 2018-2030 (USD MILLION)
TABLE 291. VIETNAM SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY SPINAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 292. VIETNAM SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY INTERBODY DEVICES, 2018-2030 (USD MILLION)
TABLE 293. VIETNAM SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 294. VIETNAM SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
TABLE 295. VIETNAM SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY DIAGNOSIS APPLICATION, 2018-2030 (USD MILLION)
TABLE 296. VIETNAM SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY COMPLEX DEFORMITY, 2018-2030 (USD MILLION)
TABLE 297. VIETNAM SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 298. VIETNAM SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 299. VIETNAM SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 300. VIETNAM SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 301. EUROPE, MIDDLE EAST & AFRICA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 302. EUROPE, MIDDLE EAST & AFRICA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY SPINAL BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 303. EUROPE, MIDDLE EAST & AFRICA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY BONE GRAFTS, 2018-2030 (USD MILLION)
TABLE 304. EUROPE, MIDDLE EAST & AFRICA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY SPINAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 305. EUROPE, MIDDLE EAST & AFRICA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY INTERBODY DEVICES, 2018-2030 (USD MILLION)
TABLE 306. EUROPE, MIDDLE EAST & AFRICA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 307. EUROPE, MIDDLE EAST & AFRICA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
TABLE 308. EUROPE, MIDDLE EAST & AFRICA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY DIAGNOSIS APPLICATION, 2018-2030 (USD MILLION)
TABLE 309. EUROPE, MIDDLE EAST & AFRICA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY COMPLEX DEFORMITY, 2018-2030 (USD MILLION)
TABLE 310. EUROPE, MIDDLE EAST & AFRICA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 311. EUROPE, MIDDLE EAST & AFRICA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 312. EUROPE, MIDDLE EAST & AFRICA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 313. EUROPE, MIDDLE EAST & AFRICA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 314. EUROPE, MIDDLE EAST & AFRICA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 315. DENMARK SPINAL DEVICES & BIOLOGI

Companies Mentioned

  • Acuity Surgical Devices, LLC
  • Aesculap Implant Systems, LLC
  • DJO, LLC
  • Exactech, Inc.
  • Innovasis, Inc.
  • Integra LifeSciences Holdings Corporation
  • Invictus Medical LLC
  • Kohlberg & Company, LLC
  • Medtronic PLC
  • NuVasive, Inc.
  • Orthofix Medical Inc.
  • Smith & Nephew PLC
  • Stryker Corporation
  • Wright Medical Group N.V.
  • Össur Group

Methodology

Loading
LOADING...

Related Topics

Related Reports

Spine Biologics Market by Product, Application, End-user - Global Forecast 2025-2030 - Product Image

Spine Biologics Market by Product, Application, End-user - Global Forecast 2025-2030

  • Report
  • 195 Pages
  • Global
From
Spine Biologics Market Report by Product, Surgery Type, End User, and Region 2024-2032 - Product Image

Spine Biologics Market Report by Product, Surgery Type, End User, and Region 2024-2032

  • Report
  • 141 Pages
  • Global
From
Spine Biologic Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F - Product Image

Spine Biologic Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F

  • Report
  • 180 Pages
  • Global
From
Spine Biologics - Global Strategic Business Report - Product Image

Spine Biologics - Global Strategic Business Report

  • Report
  • 196 Pages
  • Global
From
Spine Biologics Market Size, Share & Trends Analysis Report by Product (Spinal Allografts, Bone Graft Substitutes, Cell-Based Matrix), Surgery, End-use, Region, and Segment Forecasts, 2025-2030 - Product Image

Spine Biologics Market Size, Share & Trends Analysis Report by Product (Spinal Allografts, Bone Graft Substitutes, Cell-Based Matrix), Surgery, End-use, Region, and Segment Forecasts, 2025-2030

  • Report
  • 100 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.